Clinical Trial Update: Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat' [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BIC/F/TAF to standard of care for newly diagnosed HIV in test-and-treat context; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• BIC/F/TAF (bictegravir/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED